Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment

By A. Bakker, G. Krauss, Marilyn S. Albert, Caroline L. Speck, Lauren R. Jones, Craig E. L. Stark, Michael A. Yassa, S. Bassett, A. Shelton, M. Gallagher. Neuron, 2012

856 citations recorded by the source corpus.

Summary Elevated hippocampal activation is observed in conditions that confer risk for Alzheimer's disease, including amnestic mild cognitive impairment (aMCI). Studies in relevant animal models have indicated that over-activity in selective hippocampal circuits contributes to cognitive impairment. Here we tested the effect of reducing hippocampal activation in aMCI. Under placebo treatment, hippocampal activation in the dentate gyrus/CA3 was elevated in aMCI patients compared to a healthy control group. By using a low dose of the antiepileptic levetiracetam hippocampal activation in aMCI was reduced to a level that did not differ from the control group. Compared to aMCI memory performance under placebo, performance in the scanning task was significantly improved under drug treatment. Contrary to the view that greater hippocampal activation might serve a beneficial function, these results support the view that increased hippocampal activation in aMCI is a dysfunctional condition and that targeting excess hippocampal activity has therapeutic potential.

Subfields: Cellular and Molecular Neuroscience, Cognitive Neuroscience, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/eb3e9a291fca55870abc442c21047f8895aa0632